GlassScriptPhysician profile
Benjamin F Emanuel
NPI 1245202985
$189.11
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.75 · 2020: $56.17 · 2021: $69.19.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $28.19 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.17 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $23.12 | 2019 | |
| Secura Bio, INC. | $18.89 | 2021 | |
| Acrotech Biopharma INC. | $18.60 | 2021 | |
| Merck Sharp & Dohme LLC | $17.03 | 2021 | |
| Amgen INC. | $15.66 | 2019 | |
| Coherus Oncology, INC. | $15.51 | 2020 | |
| Alexion Pharmaceuticals, INC. | $14.67 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.27 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Emanuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.